Goldenrod Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-036/3/26 | New | $3,245,355 | $3,245,355 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Thomas Brenninkmeijer | Director |
| Dev Chatterjee | Executive |
| Leo Linbeck Iii | Director |
| Leo Linbeck Iv | Executive |
| Atul Varadhachary | Director, Executive |
| Mark Worscheh | Director, Executive |
Industry: Biotechnology (See others in industry)
Address:
3900 Essex Lane, Suite 575
Houston, TX, 77027
Phone: 713-966-5844
Houston, TX, 77027
Phone: 713-966-5844